Last updated 1 Jun 2020
Dr Peter Noone, Consultant in Occupational Medicine, HSE Dublin North East
Dr Eugene Waclawski, Honorary Srnior Lecturer, University of Glasgow
For Diabetes Types 1 and 2, see main Covid-age table
|Addisons Disease||Increased risk
Will require more medication if develops COVID-19
Tresoldi AS, et al. Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2020 Feb 1 (105) 2.
Wiebke A, Baldeweg SE, Pearce SHS, Simson HL.Endocrinology in the time of COVID-19: Management of Adrenal Insufficiency. European Journal fo Endocrinology online 01 April 2020.
|BMI||Add appropriate age for BMI level||https://www.beckershospitalreview.com/public-health/obesity-increases-risk-for-covid-19-complications-data-shows.html|
|Cushing’s disease||Low/Standard if treated||https://pituitary.org.uk/news/2020/03/coronavirus-faqs/|
|Diabetes Insipidus||Increased or low||https://pituitary.org.uk/information/publications/essential-free-publications/factsheet-to-ae-and-hospital-staff-about-diabetes-insipidus/|
|Multiple Endocrine Neoplasia
MEN syndromes, SDH (succinate dehydrogenase) syndromes, active MTC (medullary thyroid cancer) and ACC (adrenal cortical carcinoma) classed as ‘underlying’ or ‘pre-existing’ conditions/diseases, & not thought at greater risk than the general public.
Adrenal insufficiency (from adrenal or pituitary surgery), diabetes or cancer metastases (especially to the lungs) may result in an increase in the risk of a severe infection response.
If untreated, risk may be high. If secondary to other conditions,treated adrenal insufficiency vulnerablity still high.
|Prolactinoma, acromegaly, non-functioning adenoma
with no requirement for steroid replacement
Risk of severe illness or death if contracts COVID-19. Read more
Likely to need hospitalisation if contracts COVID-19, with protracted illness and heavy NHS burden. Read more
Increased risk compared with healthy individual but should recover.
No greater risk than healthy individual.